Lei Jiang

2.4k total citations
90 papers, 1.5k citations indexed

About

Lei Jiang is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lei Jiang has authored 90 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lei Jiang's work include Lymphoma Diagnosis and Treatment (9 papers), Viral gastroenteritis research and epidemiology (7 papers) and Porphyrin Metabolism and Disorders (6 papers). Lei Jiang is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), Viral gastroenteritis research and epidemiology (7 papers) and Porphyrin Metabolism and Disorders (6 papers). Lei Jiang collaborates with scholars based in China, United States and Spain. Lei Jiang's co-authors include Nailin Li, Zongxi Han, Shengwang Liu, Hu Hu, Yan Zhao, Yuqiu Chen, Wenjun Zhao, Zhangsen Huang, Chunlai Zeng and Junfeng Sun and has published in prestigious journals such as Nature Communications, Blood and PLoS ONE.

In The Last Decade

Lei Jiang

85 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Jiang China 23 620 330 283 270 198 90 1.5k
Yujie Fu China 24 846 1.4× 376 1.1× 138 0.5× 105 0.4× 229 1.2× 61 1.6k
Yasuteru Kondo Japan 29 704 1.1× 315 1.0× 33 0.1× 184 0.7× 125 0.6× 97 2.5k
Lili Sun China 28 1.4k 2.2× 293 0.9× 60 0.2× 42 0.2× 200 1.0× 106 2.2k
Keishi Fujiwara Japan 21 983 1.6× 319 1.0× 54 0.2× 57 0.2× 126 0.6× 38 2.0k
Xiaoli Shi China 13 267 0.4× 141 0.4× 58 0.2× 58 0.2× 89 0.4× 35 716
Liping Ma China 20 432 0.7× 106 0.3× 46 0.2× 44 0.2× 115 0.6× 87 1.1k
Hua Geng China 19 897 1.4× 206 0.6× 59 0.2× 97 0.4× 169 0.9× 44 1.4k
Young‐Hwa Chung South Korea 33 660 1.1× 490 1.5× 22 0.1× 211 0.8× 178 0.9× 86 2.8k
Marie‐Luise Berres Germany 26 358 0.6× 284 0.9× 30 0.1× 92 0.3× 79 0.4× 59 2.1k
Tze‐Yi Lin Taiwan 23 569 0.9× 144 0.4× 22 0.1× 110 0.4× 111 0.6× 55 1.3k

Countries citing papers authored by Lei Jiang

Since Specialization
Citations

This map shows the geographic impact of Lei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Jiang more than expected).

Fields of papers citing papers by Lei Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Jiang. The network helps show where Lei Jiang may publish in the future.

Co-authorship network of co-authors of Lei Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Jiang. A scholar is included among the top collaborators of Lei Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Jiang. Lei Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Jiang, Xia, Youhong Li, Fenglin Li, et al.. (2024). NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia. Journal of Translational Medicine. 22(1). 867–867. 2 indexed citations
5.
Yang, Yan, Ying Yin, Yuan Gao, et al.. (2024). Clinical significance of Cyclin D1 by complete quantification detection in mantle cell lymphoma: positive indicator in prognosis. Diagnostic Pathology. 19(1). 149–149. 5 indexed citations
6.
Baek, Rena, Kimberly A. Coughlan, Lei Jiang, et al.. (2024). Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria. Nature Communications. 15(1). 3804–3804. 21 indexed citations
7.
Wen, Wei, Yu‐Xin Yan, Mengjie Gao, et al.. (2024). Zedoarondiol Inhibits Neovascularization in Atherosclerotic Plaques of ApoE−/− Mice by Reducing Platelet Exosomes-Derived MiR-let-7a. Chinese Journal of Integrative Medicine. 31(3). 228–239. 1 indexed citations
8.
Jiang, Xia, Ye Lin, Mengting Zhao, et al.. (2023). Platycodin D induces apoptotic cell death through PI3K/AKT and MAPK/ERK pathways and synergizes with venetoclax in acute myeloid leukemia. European Journal of Pharmacology. 956. 175957–175957. 10 indexed citations
9.
Huang, Qinghua, et al.. (2023). PDE-5-Inhibited BMSCs Alleviate High Glucose-Induced Myocardial Fibrosis and Cardiomyocyte Apoptosis by Activating the cGMP/PKG Pathway. Frontiers in Bioscience-Landmark. 28(7). 155–155. 1 indexed citations
10.
Liu, Pu, Mengting Zhao, Lin Ye, et al.. (2023). Platycodin D induces proliferation inhibition and mitochondrial apoptosis in diffuse large B-cell lymphoma. Experimental Hematology. 123. 46–55.e1. 3 indexed citations
11.
Sampedro, Ana, Lei Jiang, Gilles Joucla, et al.. (2022). Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment. Life. 12(11). 1858–1858. 12 indexed citations
12.
Merino, María, Lei Jiang, Ana Sampedro, et al.. (2022). Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria. Science Translational Medicine. 14(627). eabc0700–eabc0700. 12 indexed citations
13.
Jiang, Lei, et al.. (2021). NUPR1 participates in YAP-mediate gastric cancer malignancy and drug resistance via AKT and p21 activation. Journal of Pharmacy and Pharmacology. 73(6). 740–748. 10 indexed citations
14.
Xiong, Anwen, Lei Jiang, June Xu, et al.. (2021). Blood digital polymerase chain reaction as a potential method to detect human epidermal growth factor receptor 2 amplification in non-small cell lung cancer. Translational Lung Cancer Research. 10(11). 4235–4249. 6 indexed citations
15.
Li, Shuting, et al.. (2020). Salvianolic acid A inhibits the growth of diffuse large B-cell lymphoma through MAPK pathways. Experimental Hematology. 94. 60–68.e2. 9 indexed citations
16.
Xu, Li‐Wen, Zongxi Han, Lei Jiang, et al.. (2018). Genetic diversity of avian infectious bronchitis virus in China in recent years. Infection Genetics and Evolution. 66. 82–94. 53 indexed citations
18.
Zhou, Qi, Lei Jiang, Dongjiao Luo, et al.. (2013). Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis. Thrombosis Research. 133(1). 57–65. 64 indexed citations
19.
Han, Lei, Lei Jiang, Hui Tan, et al.. (2013). An Atypical Case of IgG4-Related Sclerosing Pancreatitis on PET/CT Imaging. Clinical Nuclear Medicine. 39(3). e236–e238. 4 indexed citations
20.
Jiang, Lei, et al.. (2011). [Intravascular NK-cell lymphoma: a clinicopathologic study and literature review].. PubMed. 40(10). 689–93. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026